<![CDATA[Kaneka Eurogentec S.A. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=29623>Sun, 26 Apr 2026 18:40:46 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Kaneka Eurogentec Receives GMP Accreditation for New mRNA Manufacturing Facility - COVID-19 Vaccine Production Ongoing]]>https://www.newswire.co.kr/newsRead.php?no=918684Wed, 17 Feb 2021 18:00:00 +0900<![CDATA[카네카 유로젠텍, 새로운 mRNA 생산 시설 GMP 인증 획득하고 코로나19 백신 생산 추진]]>https://www.newswire.co.kr/newsRead.php?no=918685Wed, 17 Feb 2021 18:00:00 +0900<![CDATA[Kaneka Eurogentec Announces the Construction of a New Large Scale Pharmaceutical Grade Biologics Manufacturing Facility]]>https://www.newswire.co.kr/newsRead.php?no=856236Thu, 14 Sep 2017 16:30:00 +0900<![CDATA[카네카 유로젠텍, 대규모 제약 생물학 제제 제조 시설 신설 계획 발표]]>https://www.newswire.co.kr/newsRead.php?no=856237Thu, 14 Sep 2017 16:30:00 +0900